061 T cell-mediated cerebellitis after ipilimumab for small cell lung cancer
061 T cell-mediated cerebellitis after ipilimumab for small cell lung cancer
About this item
Full title
Author / Creator
Publisher
London: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Ipilimumab is an anti-CTLA4 antibody in evaluation for the treatment of small cell lung cancer. We report a case of rapidly progressive fatal cerebellitis occurring eight months after first dosing. Pre-treatment weakly positive anti-Yo antibodies did not change. Clinically asymptomatic anti-voltage-gated calcium channel antibodies developed after i...
Alternative Titles
Full title
061 T cell-mediated cerebellitis after ipilimumab for small cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2708265561
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2708265561
Other Identifiers
ISSN
0022-3050
E-ISSN
1468-330X
DOI
10.1136/jnnp-2022-ABN.98
